HOME >> BIOLOGY >> NEWS
Ovarian cancer detected in blood samples

Scientists at Johns Hopkins have successfully detected ovarian cancer using a blood test for DNA shed by tumors. The test is based on digital analysis of single nucleotide polymorphisms (SNP, or "snips"), in which investigators separate the two strands of code found in every gene to search for imbalances that are a hallmark of cancer cell DNA.

With 54 blood samples from late- and early-stage ovarian cancer patients, the Hopkins team used digital SNP analysis to find so-called "allelic imbalance" in 87 percent (13 out of 15) of early-stage ovarian cancers and 95 percent (37 out of 39) with late-stage disease. No allelic imbalance was detected in 31 blood samples from healthy individuals. The researchers also compared the type of allelic imbalance found in 17 of the samples with the corresponding tumor tissue and found that 15 of these had matching allelic imbalance patterns.

Details of the initial studies of the test are published in the November 20, 2002 issue of the Journal of the National Cancer Institute.

"Digital SNP appears to detect ovarian cancers very well and is far more precise than other available tests," says Ie-Ming Shih, M.D., Ph.D., pathologist and director of this study for the Kimmel Cancer Center at Johns Hopkins. But, Shih cautioned, digital SNP is too costly and labor intensive at present to serve as a general screening test. "Currently there still is no way to usefully screen all women for ovarian cancer," Shih says, although it might be useful for women at high risk.

The Hopkins group also is investigating ways of achieving the same accurate detection rate with a less costly, more efficient test that could be used on a broader scale for ovarian and a variety of other cancers, Shih says.

DNA released from dying cells has long been detectable in blood samples, using sensitive molecular technology. But to distinguish normal from cancerous DNA, Kimmel Cancer Center scientists analyzed bot
'"/>

Contact: Vanessa Wasta
wastava@jhmi.edu
410-955-1287
Johns Hopkins Medical Institutions
19-Nov-2002


Page: 1 2 3

Related biology news :

1. Ovarian cancer sheds tumor suppression with loss of estrogen receptor
2. Ovarian tumor cell sensitivity then resistance - to chemotherapy linked to genetic abnormality
3. Ovarian stimulation in mice adversely affects embryo development and implantation
4. Study Suggests Vaccine Increases Survival In Ovarian And Breast Cancer Patients Following High-Dose Chemotherapy And Autologous Stem Cell Transplant
5. UI Researchers Find Possible Genetic Link Between The X Chromosome And Ovarian Cancer
6. Gene Knockout Prolongs Ovarian Lifespan In Mice
7. Gene Once Thought To Program Ovarian Development Instead Found To Be Critical For Production Of Sperm
8. Cold Virus With P53 Gene Tested To Combat Ovarian Cancer
9. Multi-Center Study Provides Guidelines For Genetic Testing In Women With Breast Cancer: BRCA Abnormalities Multiply Risk Of Ovarian Cancer
10. Leader in cancer treatment and prevention research honored
11. International study findings link acne-like rash to effectiveness of new targeted cancer treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2020)... ... , ... The LaunchPort™ announced today that ExoRenal ( http://www.exorenal.com ... The newly formed company is developing a novel pulsatile hemodialysis technology that is ... dialysis treatments. The start-up company will be moving research functions from New England ...
(Date:2/5/2020)... ... 04, 2020 , ... Crystal Diagnostics (CDx) announced today that ... related to proprietary liquid crystal technology for rapid and accurate detection of foodborne ... on December 3, 2019. Together, these patents protect the company’s liquid crystal technology ...
(Date:1/29/2020)... ... 29, 2020 , ... INDIGO Biosciences, Inc. (INDIGO), the recognized ... a record earnings year for 2019. With final numbers to be released to ... increase in revenue and a thirty percent increase in gross profit, and more ...
Breaking Biology News(10 mins):
(Date:2/13/2020)... ... February 12, 2020 , ... Arriello , a ... adopting Veeva Vault Safety™ as part of the company’s continued growth ... data, processing of safety information such as SUSARs and ICSRS, aggregate report production, ...
(Date:2/10/2020)... ... , ... R3 Medical Training announced it is now registering for its next ... course is hands on involving real patients and stem cell biologics, with every attendee ... Cell Training Course has received rave reviews from attendees, who love the hands on ...
(Date:2/3/2020)... ... 03, 2020 , ... Ovation Travel Group has ... Industry Travel and Biotech/Healthcare Industry Travel Indexes. , All of the Indexes contain ... Average airfare price paid Domestically, Internationally and Overall ...
(Date:1/28/2020)... ... January 28, 2020 , ... ... for biopharmaceutical R&D, today announced the release of Genedata Expressionist ® ... supporting the implementation of Multi-Attribute Methods (MAM) for characterizing and monitoring the ...
Breaking Biology Technology:
Cached News: